| Whitewater Health Services | |
| 525 Bluff Avenue, St Charles, Minnesota 55972 | |
| (507) 932-3283 | |
| Name | Whitewater Health Services |
|---|---|
| Location | 525 Bluff Avenue, St Charles, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 45 |
| Occupancy Rate | 75.56% |
| Medicare ID (CCN) | 245270 |
| Legal Business Name | Nsh Whitewater Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1841735578 |
| Organization Name | NSH WHITEWATER LLC |
| Doing Business As | WHITEWATER HEALTH SERVICES |
| Address | 525 Bluff Ave, Saint Charles, MN 55972 |
| Phone Number | 507-932-3283 |
News Archive
In this Global Health and Diplomacy opinion piece, Tanzanian President Jakaya Mrisho Kikwete examines efforts to meet Millennium Development Goal (MDG) targets on maternal and child mortality in Africa, noting, "Although Africa has just 12 percent of the global population, it accounts for half of all maternal deaths and half the deaths of children under five."
Researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine presented new research findings in 25 presentations this weekend at the 53rd Annual Meeting of the American Society of Hematology (ASH) at the San Diego Convention Center.
Geisinger Health System received the elite Seven Seals Award from the Employer Support of the Guard and Reserve, a U.S. Department of Defense organization, in a ceremony today, July 9, at Geisinger Medical Center in Danville. The Seven Seals Award is the highest award given by ESRG, and was created to publically recognize employers who provide outstanding patriotic support and cooperation to employees and families of those who have been called to serve in the U.S. Armed Forces.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
A study published in The Journal of Maternal-Fetal and Neonatal Medicine demonstrates that the fraction of fetal cell-free DNA (cfDNA) in maternal blood is unaffected by the mother's presumed risk for trisomy, offering support for the use of non-invasive prenatal testing (NIPT) for detecting genetic conditions such as Down syndrome in a broad patient population.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In this Global Health and Diplomacy opinion piece, Tanzanian President Jakaya Mrisho Kikwete examines efforts to meet Millennium Development Goal (MDG) targets on maternal and child mortality in Africa, noting, "Although Africa has just 12 percent of the global population, it accounts for half of all maternal deaths and half the deaths of children under five."
Researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine presented new research findings in 25 presentations this weekend at the 53rd Annual Meeting of the American Society of Hematology (ASH) at the San Diego Convention Center.
Geisinger Health System received the elite Seven Seals Award from the Employer Support of the Guard and Reserve, a U.S. Department of Defense organization, in a ceremony today, July 9, at Geisinger Medical Center in Danville. The Seven Seals Award is the highest award given by ESRG, and was created to publically recognize employers who provide outstanding patriotic support and cooperation to employees and families of those who have been called to serve in the U.S. Armed Forces.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
A study published in The Journal of Maternal-Fetal and Neonatal Medicine demonstrates that the fraction of fetal cell-free DNA (cfDNA) in maternal blood is unaffected by the mother's presumed risk for trisomy, offering support for the use of non-invasive prenatal testing (NIPT) for detecting genetic conditions such as Down syndrome in a broad patient population.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.63 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.57 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.24 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.6 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 23 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.79 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.5 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.44 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.29 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.52 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.24 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.09 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.49 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.26 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 72.9 | 82.93 |
News Archive
In this Global Health and Diplomacy opinion piece, Tanzanian President Jakaya Mrisho Kikwete examines efforts to meet Millennium Development Goal (MDG) targets on maternal and child mortality in Africa, noting, "Although Africa has just 12 percent of the global population, it accounts for half of all maternal deaths and half the deaths of children under five."
Researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine presented new research findings in 25 presentations this weekend at the 53rd Annual Meeting of the American Society of Hematology (ASH) at the San Diego Convention Center.
Geisinger Health System received the elite Seven Seals Award from the Employer Support of the Guard and Reserve, a U.S. Department of Defense organization, in a ceremony today, July 9, at Geisinger Medical Center in Danville. The Seven Seals Award is the highest award given by ESRG, and was created to publically recognize employers who provide outstanding patriotic support and cooperation to employees and families of those who have been called to serve in the U.S. Armed Forces.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
A study published in The Journal of Maternal-Fetal and Neonatal Medicine demonstrates that the fraction of fetal cell-free DNA (cfDNA) in maternal blood is unaffected by the mother's presumed risk for trisomy, offering support for the use of non-invasive prenatal testing (NIPT) for detecting genetic conditions such as Down syndrome in a broad patient population.
› Verified 1 days ago
Whitewater Health Services Location: 525 Bluff Avenue, St Charles, Minnesota 55972 Phone: (507) 932-3283 |